Last update 01 Nov 2024

CS-Bay Therapeutics

United States
|
csbaytherapeutics.com

Overview

Tags

Neoplasms
Other Diseases
Small molecule drug
Interleukins
Drug conjugates

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms8
Top 5 Drug TypeCount
Small molecule drug4
Unknown2
Drug conjugates1
Monoclonal antibody1
Interleukins1
Top 5 TargetCount
STING(Stimulator of interferon genes)3
STING x TLR91
CDK4 x CDK61
CD80 x PDL11
CLDN18(Claudin-18)1

Related

9
Drugs associated with CS-Bay Therapeutics
Anti-CLDN18.2 antibody (CS Bay Therapeutics)
Target
CLDN18
Mechanism
CLDN18 modulators
Active Org.
CS-Bay Therapeutics
Originator Org.
CS-Bay Therapeutics
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
CS-1010
Target
STING
Mechanism
STING agonists
Active Org.
CS-Bay Therapeutics
Originator Org.
CS-Bay Therapeutics
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
CS-2087
Target
IL-2
Mechanism
IL-2 replacements
Active Org.
CS-Bay Therapeutics
Originator Org.
CS-Bay Therapeutics
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with CS-Bay Therapeutics
Login to view more data
0 Patents (Medical) associated with CS-Bay Therapeutics
Login to view more data
100 Deals associated with CS-Bay Therapeutics
Login to view more data
100 Translational Medicine associated with CS-Bay Therapeutics
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 28 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
8
1
Phase 1 Clinical
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free